About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Asthma and Quantifying Delivery Of Radio Labeled Aerosol

Asthma and Quantifying Delivery Of Radio Labeled Aerosol

NCT01823926·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Universidade Federal de Pernambuco

Age

18–60

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

stable moderate to severe asthma (FEV1 \> 60% and \> 80% and PEF with a variation of 30% from the predicted values to moderate and FVE1 \> 60% and );
More than one year elapsed since the diagnosis of asthma;
None exacerbation in the last six months;
Age between 18 - 60 years, from both sexes,
Able to understand verbal commands
Consent to participate in this protocol.

You may not be if

presence of dyspnea;
smoking history;
cardiopulmonary diseases (chronic obstructive pulmonary disease, pneumonia, cardiac failure, myocardial infarction, pneumothorax);
hyperthermia;
hemodynamic instability (heart rate \> 150 bpm and systolic blood pressure \< 90 mmHg);
arrhythmia absence;
pregnancy
contraindications for use of noninvasive ventilation

The record

StatusCompleted

PhaseNo phase

Taking part13

StartedOct 2011

UpdatedApr 4, 2013

Conditions

Where1

Hospital das Clínicas de Pernambuco
Recife, Pernambuco, Brazil